0001437749-25-034843
SEC filingAXT's Q3 2025 revenue grew 18.2% YoY to $28.0M driven by InP demand recovery from new China export approvals, but nine-month gross profit fell 67.0% due to GaAs yield issues and export restrictions.
AXT, Inc. reported Q3 2025 revenue of $28.0 million, an 18.2% increase from $23.6 million in Q3 2024. This growth was entirely driven by a 41.7% surge in substrate revenue to $21.3 million, primarily from higher demand for indium phosphide (InP) wafers used in data center connectivity and passive optical networks. The recovery followed the receipt of initial export permits from China's Ministry of Commerce on June 11, 2025, allowing resumption of InP shipments to certain customers in Europe and Japan. Raw materials revenue declined 22.5% to $6.7 million due to weaker market demand for refined gallium and pBN crucibles.
Gross profit for Q3 2025 increased 9.5% to $6.2 million, with gross margin of 22.3% compared to 24.0% in the prior-year quarter. The improvement was attributed to higher revenue spreading fixed costs over more units and a favorable product mix shift. However, the nine-month performance tells a starkly different story: revenue decreased 12.1% to $65.3 million, and gross profit collapsed 67.0% to $6.4 million, yielding a gross margin of only 9.8% versus 26.2% in the prior-year period. This deterioration was caused by significant unfavorable yields in gallium arsenide (GaAs) production lines, which resulted in negative gross margins as a percentage of revenue, and unabsorbed overhead from reduced substrate sales due to China's export restrictions on InP imposed on February 4, 2025.
Selling, general and administrative expenses increased 12.1% to $6.3 million in Q3 2025, driven by higher compensation and legal costs. Research and development expenses decreased sharply by 70.5% to $1.0 million, attributed to one-time benefits of certain materials. The net loss attributable to noncontrolling interests and redeemable noncontrolling interests was an income of $0.2 million in Q3 2025, reflecting higher profitability from PRC subsidiaries as sales increased.
The substrate segment, which generated 68% of 2024 consolidated revenue, experienced extreme volatility. InP substrates, the primary revenue driver for U.S. imports, were severely impacted when China added them to its export control list on February 4, 2025. The subsequent granting of export permits to Europe, Japan, the UK, and Canada in June 2025 enabled a partial recovery, with Taiwan revenue surging 322.7% to $9.0 million in Q3 2025. However, North America revenue plummeted 94.5% to just $0.1 million, representing only 1% of total revenue, as no permits for GaAs exports to the U.S. were approved and U.S. tariffs on Chinese wafer substrates escalated to approximately 100% by April 2025.
The raw materials segment, contributing 32% of 2024 revenue, faced headwinds from weaker market demand for refined gallium and pBN crucibles. China remained the dominant geographic market at 47% of Q3 2025 revenue, though absolute revenue there decreased 4.8% due to lower demand for germanium wafers and refined gallium.
Management faces a highly uncertain operating environment shaped by escalating U.S.-China trade tensions. The STAR Market IPO for subsidiary Tongmei remains pending CSRC approval, with a potential $49 million redemption obligation to private equity investors if the listing fails. The company filed a $100 million shelf registration statement on November 7, 2025, for potential future capital raises. With $31.2 million in cash and restricted cash as of September 30, 2025, management believes it has adequate liquidity for the next 12 months, though this depends on the trajectory of export permit approvals and tariff resolutions. The company is actively monitoring trade policy shifts and evaluating mitigation strategies, but the timing for receiving U.S.-bound InP export permits remains uncertain.
As of September 30, 2025, AXT, Inc. reported cash and cash equivalents of $23.1 million and restricted cash of $8.1 million, for a combined total of $31.2 million. This represents a decrease from $33.8 million at December 31, 2024. The company held no available-for-sale debt securities. Total current liabilities stood at $84.9 million, driven primarily by $61.5 million in short-term loans, a significant increase from $47.3 million at year-end 2024. The short-term loan balance includes $57.0 million in short-term bank loans and $4.5 million representing the current portion of long-term debt. Total stockholders' equity was $202.3 million, down from $216.3 million at year-end, primarily due to a net loss and an accumulated deficit of $61.4 million. Inventory decreased to $77.7 million from $85.1 million, net of reserves for excess and obsolete inventory of $27.1 million.
AXT has a cross-license and covenant agreement with a competitor, effective January 1, 2020, and expiring December 31, 2029. The agreement requires fixed annual payments over the 10-year term; however, the specific annual or total commitment amount is not disclosed in the notes. The company also has cooperation agreements with local governments in Dingxing and Kazuo, China, targeting total investments of approximately $90 million and $15 million, respectively, in value, assets, and capital, though these are good faith covenants without specific penalties or deadlines. As of September 30, 2025, AXT had no outstanding purchase orders that would incur a penalty if cancelled. Contract liabilities, representing advance payments from customers, were $0.5 million.
During the nine months ended September 30, 2025, AXT invested $3.0 million in purchases of property, plant, and equipment. The company did not repurchase any shares of its common stock under its existing $5.0 million repurchase program, leaving $2.7 million available for future repurchases. No new repurchase authorization was announced. Preferred stock dividends of $132,000 were accrued for the period. Financing activities provided net cash of $11.8 million, primarily from $43.3 million in proceeds from short-term bank loans, partially offset by $33.6 million in repayments. The company also received $3.2 million in proceeds from long-term loans and made $1.1 million in payments on long-term loans.
AXT operates as a single operating segment focused on the design, development, manufacture, and distribution of high-performance compound and single-element semiconductor substrates. Revenue for the nine months ended September 30, 2025, was $65.3 million, with substrates contributing $43.6 million and raw materials and other contributing $21.7 million. Geographically, China was the largest market at $41.1 million, followed by Taiwan ($10.8 million) and Europe ($7.1 million). Two customers represented 19% and 13% of revenue for the three-month period, but no single customer exceeded 10% for the nine-month period.
For the nine months ended September 30, 2025, AXT, Inc. reported a net loss of $19.4 million, which was the primary driver of the $17.1 million net cash used in operating activities. This represents a deterioration from the $13.4 million used in the prior year period, with the operating cash flow deficit widening by 27.6% year-over-year. The gap between net loss and operating cash flow was partially bridged by non-cash adjustments, notably $6.8 million in depreciation and amortization and $2.0 million in stock-based compensation. However, working capital movements presented a mixed picture: a $9.1 million reduction in inventories provided a significant source of cash, while a $7.7 million increase in accounts receivable and a $5.2 million decrease in other long-term liabilities were substantial drains.
Capital expenditure intensity moderated, with purchases of property, plant and equipment declining to $3.0 million from $5.6 million in the prior year. Despite this reduction, the company's negative free cash flow (operating cash flow plus capex) remains a concern, as internally generated cash is insufficient to fund investments. The company relied on external financing to bridge the gap, generating $11.8 million in net cash from financing activities, predominantly through net proceeds from short-term bank loans. No share repurchases or dividends were paid, indicating a focus on preserving liquidity. An anomaly to note is the $6.5 million positive effect of exchange rate changes on cash, which partially offset the overall net cash decrease for the period.